Therefore, our data suggest that high susceptibility to TRAIL of metastatic cancer cells is associated with up-regulation of DR5 and concurrent down-regulation of c-FLIPL/S and Mcl-1. The gene discussed is TNFRSF10B; the disease is cancer.